The first comprehensive map of the dramatic changes that take place in the blood system over the course of the human lifetime could have implications for the treatment of acute myeloid leukemia and ...
Researchers at University of California San Diego School of Medicine and their colleagues have developed the first ...
India has successfully conducted its first in-human gene therapy for hemophilia A, with patients experiencing no bleeding ...
In the groundbreaking study the researchers observed an annualised zero bleeding rate in all the five subjects enrolled with ...
Current treatments require frequent Factor VIII replacement therapy, which faces challenges such as high costs, venous access ...
Indian scientists successfully use gene therapy to treat severe haemophilia A, a rare hereditary condition with promising ...
SAN DIEGO -- Results from a small single-center study showed that treatment with a gene therapy involving the use of ...
Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 66th Annual Meeting and Exposition. This year’s ...
A Phase 3 trial of uproleselan failed to improve overall survival in relapsed/refractory AML, though it may benefit primary ...
By illuminating how diet and other lifestyle factors may affect a person's likelihood of developing a blood disorder as well as disease progression and response to treatment, the studies point to ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced longer-term data for CASGEVY™ (exagamglogene autotemcel) from global clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback